Drug Filter >
  • Aprv. Year: 1998
  •   > 
Drug Filter
Category:
Chemicals (24) Biologics (11)
Bio-Type:
Vaccine (1) Recombinant enzyme (1) Recombinant cytokines (1) Recombinant hormone (3) Whole antibody (4) Fusion protein (1)
Company:
Pfizer (5) Merck Sharp & Dohme (4) Eisai (3) Novartis (3) Roche (3) Abbvie (2) Astellas (2) Boehringer Ingelheim (2) Chugai (2) Genzyme (2) Sanofi (2) Takeda (2) Alcon (1) Amgen (1) Apotex (1) Asahi Kasei (1) Bausch & Lomb (1) Bayer (1) Bristol-Myers Squibb (1) Celgene (1) Endo (1) Genentech (1) GlaxoSmithKline (1) Janssen (1) Lilly (1) MedImmune (1) Medicure (1) Merck Serono (1) Millennium Pharmaceutical (1) Mitsubishi Tanabe Pharma (1) Novo Nordisk (1) Orion (1) Procter & Gamble (1) ViiV Healthcare (1) Warner chilcott (1) 未知 (0)
Indication:
Acne (1) Acute coronary syndrome (ACS) (2) Advanced breast cancer (1) Allergic conjunctivitis (1) Alzheimer's disease (AD) (1) BCG-refractory carcinoma in situ of the urinary bladder (1) Benign prostatic hypertrophy (2) Bladder cancer (1) Breast cancer (2) Cardiovascular risk reduction (1) Conjunctivitis (1) Mucocutaneous lymph node syndrome (Kawasaki syndrome) (1) Crohn's disease (1) Dysuria (1) Erectile dysfunction (ED) (1) Erythema nodosum leprosum (ENL) (1) Gastric cancer (2) Pediatric plaque psoriasis (1) Herpes zoster keratitis (1) HIV infection (2) Hypertension (1) Juvenile rheumatoid arthritis (JRA) (2) Aplastic anaemia (1) Metastatic breast cancer (1) Metastatic colorectal cancer (CRC) (1) Metastatic gastric carcinoma (2) Migraine (1) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (3) Non-ST elevation acute coronary syndrome (NSTE-ACS) (1) Obesity (1) Ocular hypertension (1) Open-angle glaucoma (1) Osteoarthritis (OA) (1) Osteoporosis (1) Overactive bladder (OAB) (1) Paget's disease (1) Parkinson's disease (PD) (2) Percutaneous coronary intervention (PCI) (1) Postmenopausal osteoporosis (1) Psoriasis (1) Psoriatic arthritis (3) Pulmonary arterial hypertension (1) Rejection of organ transplantation (2) Rheumatoid arthritis (RA) (4) Secondary hyperparathyroidism (HPT) (1) Solid tumours (1) Superficial punctate keratitis (1) Thrombotic cardiovascular events (TCE) (1) Thyroid cancer (1) Tuberculosis (1) Ulcerative colitis (1) Urinary frequency (1) Urinary incontinence (1) Urinary urgency (1) Uveitis (1) Cardiac ischemic complications (1) Colorectal cancer (1) Rejection of renal transplantation (2) Rejection of liver transplantation (1) Rejection of lung transplantation (1) Rejection of pancreatic transplantation (1) Ankylosing Spondylitis (AS) (3) Primary dysmenorrhea (PD) (1) Familial adenomatous polyposis (FAP) (1) Iritis (1) Cyclitis (1) Acute pain (AP) (1) Low back pain (1) Shoulder periarthritis (1) Tendonitis (1) Cervico-omo-brachial syndrome (1) After surgery, post-traumatic and anti-inflammatory (1) Postoperative inflammation and pain following ocular surgery (1) Osteoporosis in men (1) Glucocorticoid-induced osteoporosis (1) Chronic kidney disease (1) Colon cancer (1) Spondyloarthritis (1) Acute angina (1) Pain (1) Stroke (1) Advanced breast cancer in postmenopausal women (1) Estrogen-receptor positive early breast cancer (1) Rejection in heart transplantation (1) Lower respiratory tract disease caused by RSV (1) Diagnostic agents (1) Behcet's disease (1) Gastroesophageal junction adenocarcinoma (1) Pediatric Crohn’s disease (1) Pediatric ulcerative colitis (1) Acute myocardial infarction (AMI) (1) Acute massive pulmonary embolism (1) Hypoglycemia (2) Iron overload (1) Plaque psoriasis (1) Thelassemia (1) Pustular psoriasis (1) Psoriatic erythroderma (1) Psoriasis vulgaris (1) Juvenile idiopathic arthritis (JIA) (1) Ocular inflammation (1)
Country:
US (26) JP (2) EU (5) GB (1) MX (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:

CopyRight©2017药渡经纬信息科技(北京)有限公司 电子与信息服务业务经营许可证151001号

京ICP备14047345| 京公安网备11010802017043号 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)

药渡APP Drug A-Z
药渡APP
药渡微信二维码
微信二维码